Laura Gil, MD
Anesthesiology · Jacksonville, FLNPI 1003349499
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $9,229 of the $15,370 with a category attached, or 60.0%. 31 manufacturers reported payments, led by Abbott at 44.8% of the total. Reporting peaked in 2022 at $8,731 and has fallen 93.5% since, to $570 in 2025. Among anesthesiology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 179 payments — averaging $85.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$7K
- Boston Scientific$3K
- Relievant Medsystems, Inc.$1K
- Medtronic$870
- SPR Therapeutics, Inc$626
- Nevro Corp.$318
- plus $2K from 25 others
What the payments were for
- Travel & lodging$9,22960%
- Food & beverage$6,12540%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 51 | $6,887 |
| Boston Scientific | 21 | $3,331 |
| Relievant Medsystems, Inc. | 7 | $1,244 |
| Medtronic | 12 | $870 |
| SPR Therapeutics, Inc | 8 | $626 |
| Nevro Corp. | 5 | $318 |
| AbbVie(2 entities) | 17 | $312 |
| Curonix LLC | 10 | $290 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $181 |
| Lundbeck LLC | 3 | $158 |
| MML US, Inc. | 1 | $147 |
| Vertex | 2 | $143 |
| GRT US Holding, Inc. | 1 | $126 |
| Saluda Medical Americas, Inc. | 1 | $106 |
| Collegium Pharmaceutical, Inc. | 5 | $103 |
| Valinor Pharma, LLC | 4 | $82 |
| Forte Bio-pharma LLC | 4 | $67 |
| Acacia Pharma Inc | 1 | $54 |
| Si-bone, Inc. | 2 | $41 |
| Biotronik NRO, Inc. | 2 | $41 |
| Almatica Pharma LLC | 2 | $37 |
| Bioventus LLC | 1 | $32 |
| Baxter Healthcare | 1 | $26 |
| Tonix Medicines, Inc. | 1 | $25 |
| Protega Pharmaceutials Inc | 1 | $21 |
| Painteq LLC | 1 | $19 |
| Foundation Fusion Solutions, LLC | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Masimo Corporation | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Globus Medical | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$2,843
- Superion Indirect Decompression System$2,682
- Intracept$2,175
- Proclaim DRG IPG$1,197
- PRODIGY$1,069
- Proclaim IPG$946
- SPRINT PNS System$442
- SYNCHROMEDII$272
- INTELLIS ADAPTIVESTIM$251
- ReActiv8$147
- BIONIC NAVIGATOR$129
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$128
- Qutenza$126
- VYEPTI$113
- Senza$113
- Evoke SCS$106
How this compares
$15,370 in reported general payments places this provider in the 95th percentile of 2,767 anesthesiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 12 | $19,294 |
| QuliptaAtogepant | 11 | $11,468 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 380 | $11,240 |
| MovantikNaloxegol Oxalate | 22 | $8,831 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 225 | $7,188 |
| Buprenorphine | 19 | $5,977 |
| Pregabalin | 146 | $3,677 |
| Lidocaine | 20 | $3,281 |
| Gabapentin | 248 | $2,632 |
| Diclofenac Sodium | 21 | $1,764 |
| Tramadol Hcl | 128 | $1,329 |
| Methocarbamol | 77 | $1,140 |
| Tizanidine Hcl | 75 | $1,091 |
| Oxycodone Hcl | 79 | $891 |
| Baclofen | 57 | $656 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $312 | $30,76223 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,767 anesthesiology providers in Florida.
Other anesthesiology in Jacksonville
- Sorin BrullJacksonville$66K
- Steven ClendenenJacksonville$28K
- M Elizabeth PerryJacksonville$28K
- Robert BryskinJacksonville$23K
- Wolf StapelfeldtJacksonville$21K
- Johnathan RenewJacksonville$19K
- Klaus TorpJacksonville$13K
- Abuzar BaloachJacksonville$11K
- Vincent KasperJacksonville$10K
- Tochukwu IbeJacksonville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.